Kemp Dolliver

Senior Analyst/Director of Research

Kemp Dolliver, CFA, is an accomplished healthcare finance executive with extensive experience in the capital markets in buy-side and sell-side roles in both the US and emerging Asia focused on biopharma and healthcare services. Noteworthy achievements as a sell-side analyst include marketing public offerings that raised over $5 billion; recognition four times for stock-picking in the WSJ’s annual “Best on the Street” survey; and building relationships with a broad universe of institutional investors and industry executives. Buy-side achievements include co-managing $2.5 billion in value-oriented equities; and making a major contribution to the outperformance of a top-decile ranked fund in the in PIPER Large Cap Universe. Numerous financial print and broadcast media have sought his views on the healthcare sector.

Talks About
#research #biology

Preferred Locations
#Northamerica